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Abstract
Activation of the transcription factor NF-kB appears to be involved in different stages of atherogenesis. In this paper we
investigate the role of NF-kB inhibitor IkBa in atherosclerosis. Myeloid-specific deletion of IkBa results in larger and more
advanced lesions in LDL-R-deficient mice without affecting the compositional phenotype of the plaques or systemic
inflammatory markers in the plasma. We show that IkBa-deleted macrophages display enhanced adhesion to an in vitro
endothelial cell layer, coinciding with an increased expression of the chemokine CCL5. Also, in vivo we found that IkBa
del
mice had more leukocytes adhering to the luminal side of the endothelial cell layers that cover the atherosclerotic plaques.
Moreover, we introduce ER-MP58 in this paper as a new immunohistochemical tool for quantifying newly recruited myeloid
cells in the atherosclerotic lesion. This staining confirms that in IkBa
del mice more leukocytes are attracted to the plaques. In
conclusion, we show that IkBa deletion in myeloid cells promotes atherogenesis, probably through an induced leukocyte
recruitment to plaques.
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Introduction
NF-kB is a transcription factor that translates the inflammatory
stimuli from the environment into gene expression patterns regu-
lating cell differentiation, activation, proliferation and apoptosis as
well as the production of a set of inflammatory mediators. It is
activated in response to pathogen detection by Toll-like receptor
signaling or, in the inflammatory milieu, through different cyto-
kine receptors such as the TNF receptor. Also, non-pathogen
related activation, called ‘‘sterile inflammation’’, including stimuli
such as free radicals, radiation and modified lipoproteins, can
trigger NF-kB [1,2].
Rather than one transcription factor, NF-kBi si nf a c taf a m i l y
of homo- and heterodimers, with different possible combinations
of the Rel-domain containing proteins NF-kB1 (p50 and its
precursor p105), NF-kB2 (p52 and its precursor p100), RelA
(p65), RelB and c-Rel. In the absence of an activating stimulus,
the NF-kB dimer is kept cytoplasmic because its nuclear lo-
calization signal is covered by an inhibitor belonging to the IkB
family [3]. The IkB family consists of IkBa,I kBb,I kBc,I kBe
and Bcl-3 [4]. Following a signaling cascade initiated by an
inflammatory stimulus, IkB is phosphorylated by a complex
consisting of IkB kinase 1 (IKK1 or IKKa), IKK2 (or IKKb)a n d
NEMO (or IKKc). This phosphorylation leads to ubiquitination
and subsequent proteasomal degradation of the IkB, leaving NF-
kB free to translocate to the nucleus [5]. Being NF-kB target
genes themselves, the IkB family members are part of a negative
feedback loop, retracting NF-kB from the nucleus back into the
cytoplasm and thereby preventing excessive and irreversible NF-
kB activation [6].
NF-kB activation is an important response in different infectious
as well as non-infectious pathologies. Also in the different stages of
atherogenesis, from early endothelial activation to eventual plaque
rupture, NF-kB has been described as a key regulator [7,8].
Atherosclerosis is a slowly progressing, chronic inflammatory di-
sease of the large arteries representing the most common cause of
death in western society [9]. This process is initiated when modi-
fied lipoproteins in the vessel wall activate the endothelial lining of
the vessel, thereby attracting monocytes, which differentiate into
macrophages upon migration through the endothelium. By taking
up and storing the lipoproteins, these macrophages eventually
become large foam cells and start secreting inflammatory me-
diators, cytokines and chemokines. The thereby created inflam-
matory environment attracts even more monocytes as well as other
immune cells to the vessel wall, forming an atherosclerotic plaque
[10].
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22327In the atherosclerotic plaque, a wide variety of NF-kB inducers
is present, ranging from modified lipoproteins to inflammatory
mediators, free radicals and remnants of dead cells [11,12,13].
Therefore, activated NF-kB has been found in different cell types
in the lesion, including macrophages, smooth muscle cells and
endothelial cells [8,14]. To investigate the importance of this
activation, we have previously studied models with either a
macrophage- [15] or endothelial cell-specific [16] ablation in NF-
kB activation. While macrophage-specific deletion of IKK2 led to
larger and more advanced lesions, endothelium-restricted NEMO
deletion abrogated atherogenesis by impairing macrophage re-
cruitment to the plaque.
In this paper we aimed at investigating the role of the NF-kB
inhibitor IkBa in atherogenesis. Since full IkBa knockout mice die
neonatal of hypergranulopoiesis and severe dermatitis [17,18,19],
we used a conditional model with a myeloid specific deletion of
IkBa [20]. Bone marrow from these LysMCre-IkBa
fl/fl mice was
transplanted into atherosclerosis-susceptible ldlr
2/2 mice to study
the effect of myeloid IkBa deficiency on atherogenesis. We found
that myeloid IkBa deficiency promotes atherogenesis by causing
increased attraction of myeloid cells to the developing plaques
without affecting other phenotypical characteristics of the lesions.
Quite surprisingly, macrophage IkBa deficiency does not seem to
affect the production of a number of NF-kB target genes in vivo nor
in vitro but appears to be involved in the adhesion and recruitment
of these cells to the atherosclerotic plaque.
Results
Myeloid IkBa deficiency promotes atherogenesis without
altering plaque phenotype, body weight, plasma lipids
and cytokines
To study the effect of myeloid IkBa deficiency on atheroscle-
rosis, bone marrow was isolated from IkBa
fl/fl and LysMCre-
IkBa
fl/fl mice, the latter having a myeloid-specific deletion of the
IkBa gene [20]. This bone marrow was transplanted into irra-
diated ldlr
2/2 mice, resulting in atherosclerosis-susceptible mice
that were either wildtype (IkBa
WT) or deleted (IkBa
del) for IkBa in
their myeloid cells. Four weeks after transplantation, these mice
were put on a high fat diet for 12 weeks in order to induce
atherogenesis. The rise in plasma cholesterol, plasma triglycerides
and body weight as a result of the diet was similar in both groups
(Figures 1A, 1B and 1C). In addition, relative levels of circulating
leukocyte populations (monocytes, granulocytes, T and B lym-
phocytes) after the transplantation did not differ between the
groups (data not shown). After 12 weeks of diet, plasma levels of
the NF-kB dependent pro-inflammatory cytokines IL-6, IL-12,
TNF-a and IFNc, the anti-inflammatory cytokine IL-10 and the
Figure 1. Plasma values and body weight of mice transplanted with either IkBa
fl/fl or LysMCre-IkBa
fl/fl bone marrow. (A) Cholesterol
levels, (B) triglyceride levels and (C) body weight measured before the start of the high fat diet (0w HFD), after 4 weeks of diet (4w HFD) and upon
sacrifice of the mice (12w HFD). (D–I) Plasma cytokine concentrations at the end of the experiment, measured by a bead array.
doi:10.1371/journal.pone.0022327.g001
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myeloid IkBa (Figures 1D–1I).
Upon sacrifice, atherosclerosis in the aortic root was analyzed.
Interestingly, lesion area measurements using toluidine blue-
stained sections (Figures 2A, 2B) showed a two-fold, significant
increase in plaque formation in IkBa
del mice compared to IkBa
WT
mice (4974069142 mm
2 vs. 9433068803 mm
2 for IkBa
WT and
myeloid-specific IkBa
del respectively; p=0.0014) (Figure 2C).
Moreover, classification of the lesions according to their severity
showed that IkBa
del mice had relatively more advanced and
less early atherosclerotic lesions (Chi square test; p,0.0001)
(Figure 2D).
With additional analyses on sections of the aortic root, the
phenotype of these plaques was further characterized. Plaque-
stabilizing collagen was stained with Sirius Red but no significant
differences were found in collagen content between the two groups
(Figure 3A). Also analysis of T cell and neutrophil content revealed
no significant differences (Figures 3B and 3C). Finally, both groups
appeared to have the same number of proliferating and apoptotic
cells in their plaques, as shown by Ki-67 and a TUNEL stainings
(Figures 3D and 3E). Thus despite having larger and more
advanced lesions, the IkBa
del lesions showed no other changes in
their plaque characteristics.
Next to the lesions in the aortic root, atherosclerotic plaque
formation was also assessed in the aortic arch. In RNA isolated
from this tissue, a 49.6% increase in the expression of macrophage
marker CD68 was found (p=0.0384, data not shown), indicating
enhanced macrophage accumulation in the vessel wall of IkBa
del-
transplanted mice.
Myeloid IkBa deficiency promotes in vitro macrophage
adhesion
To investigate the mechanism behind the enhanced athero-
genesis in the IkBa
del mice, in vitro experiments were done.
Surprisingly, the reduced production of IkBa shown in Figure 4A
and Figure S1A did not result in an increased activation of the p65
NF-kB subunit (Figure S1B–C), suggesting a potent compensatory
mechanism operating in the absence of IkBa. As a result, hardly
any difference was found in the expression of some genes known to
be NF-kB targets, NF-kB inhibitors or inflammatory mediators
when assessed in unstimulated as well as LPS stimulated bone
marrow-derived macrophages from LysMCre-IkBa
fl/fl mice and
compared to wild type cells (Figure 4A and Figure S1D). How-
ever, the expression of the chemokine CCL5 (or RANTES) was
significantly elevated 2.8 fold in macrophages lacking IkBa. CCL5
was previously shown to be involved in the adhesion of macro-
phages to endothelial cells. In line with these findings, static
adhesion of IkBa
del macrophages to a monolayer of the bEND.5
endothelial cell line was significantly enhanced compared to wild-
type macrophages (1461061163 AU vs. 2172061810 AU for
IkBa
WT and IkBa
del respectively; p=0.0298) (Figure 4B).
Atherosclerotic lesions in mice lacking myeloid IkBa
show increased leukocyte adhesion and migration
To investigate whether the observed increased in vitro macro-
phage adhesion could also be observed in the in vivo atherosclerosis
model, cells adhering to luminal side of the endothelial cells
covering the atherosclerotic plaques were quantified in the
toluidine blue-stained sections. Indeed, the IkBa
del mice displayed
Figure 2. Myeloid IkBa deficiency promotes atherosclerosis in ldlr
2/2 mice. Representative pictures of toluidine blue-stained sections in the
aortic root of (A) IkBa
WT or (B) myeloid-specific IkBa
del mice, original magnification640. (C) Lesion area in the aortic root of IkBa
WT and IkBa
del mice
(** p,0.01; n=18/16). (D) Lesion severity in the aortic root of IkBa
WT and IkBa
del mice (Chi square test; *** p,0.0001; n=54/48) was typed as absent
(0), early (1+2), or advanced (4+5), as described before [15].
doi:10.1371/journal.pone.0022327.g002
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IkBa
WT mice (7.861.3 cells vs. 15.961.8 cells for IkBa
WT and
IkBa
del respectively; p=0.0009) (Figures 5A–5C), suggesting en-
hanced recruitment of new cells to the plaque in mice lacking IkBa
in their myeloid cells.
To further analyze this recruitment of monocytes to the lesions,
we used a marker that is specifically expressed on circulating
immature myeloid cells but that is lost upon differentiation to
macrophages. This marker, detected by the antibody ER-MP58,
has previously been used in other studies to analyze recruitment of
cells from the circulation to tissues [21,22,23]. Sections from the
aortic root were stained with ER-MP58 and positive cells were
quantified. As expected, these cells were predominantly observed
on the luminal side of the plaque. However, also on the adventitial
side, some myeloid recruitment could be observed. Interestingly,
ER-MP58-positive cells were also seen in inflammatory regions in
the vicinity of the plaques. Quantification showed that IkBa
del
mice had significantly more newly recruited myeloid cells in their
plaques compared to IkBa
WT mice (15.89063.164 cells vs. 37.590
65.568 cells; p=0.0014) (Figures 5D–5F). These data indicate
that atherosclerotic lesions in the aorta of ldlr
2/2 mice lacking
myeloid IkBa may be larger because of enhanced recruitment and
infiltration of myeloid cells, suggesting that myeloid IkBa is
important in regulating the migratory phenotype of cells in
atherogenesis. A possible role for CCL5 in this mechanism is
illustrated by the observation that the expression of this chemokine
was significantly elevated in the aforementioned aortic arch-
derived RNA (40.7% increase, p=0.0270, data not shown).
Discussion
In this paper we show that myeloid-specific deletion of the
inhibitor of NF-kB, IkBa,i nldlr
2/2 mice results in larger
atherosclerotic plaques without affecting the general plaque
composition. Studying cell adhesion to the luminal side of the
endothelial layer covering atherosclerotic plaques, we observed
increased adhesion of leukocytes in the absence of myeloid IkBa.
Through a marker specific for circulating myelomonocytic cells
that is lost upon maturation to macrophages, ER-MP58, we found
that lesions from mice lacking myeloid IkBa are characterized by
more newly recruited leukocytes. Moreover, we found an increase
in macrophage content in the vessel wall of the aorta. These data
suggest that IkBa in myeloid cells may have a pivotal role in
regulating the recruitment of cells to atherosclerotic lesions.
Atherosclerosis is known to be driven by inflammation and
aggravated by the production of pro-inflammatory cytokines [24].
Since cytokine expression is highly dependent on NF-kB, it can be
expected that the atherosclerotic process is proportional to the
activation level of this transcription factor. Indeed, Gareus et al.
showed that endothelial-specific inhibition of NF-kB by NEMO
deletion impaired macrophage recruitment to the plaque and
hereby impaired atherogenesis [16]. Another paper, by Wolfrum
et al., describes how haploinsufficiency for the NF-kB activation
inhibitor A20 results in enhanced atherogenesis while A20 over-
expression reduced plaque formation [25]. Our group also showed
that the role of NF-kB in macrophages is not as straightforward.
Myeloid-specific blocking of the canonical activation of NF-kB
through deletion of IKK2 resulted in plaques that were not only
larger but also more advanced and more necrotic, highlighting the
fact that NF-kB also acts as an anti-apoptotic transcription factor
and is involved in regulating anti-inflammatory mechanisms [15].
In contrast, the present study demonstrates that deletion of
myeloid IkBa, aiming at myeloid-specific NF-kB activation, also
induces larger and more advanced plaques but without affecting
the plaque composition.
Figure 3. Myeloid IkBa deficiency does not influence plaque phenotypic characteristics. (A) Collagen content is not different between
IkBa
WT and IkBa
del mice, as shown by a Sirius Red staining. Also the relative number of (B) T cells, (C) neutrophils, (D) proliferating and (E) apoptotic
cells was similar in both groups.
doi:10.1371/journal.pone.0022327.g003
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fl/fl bone marrow-
derived macrophages and comparing it to wildtype cells, we found
an increase in the expression of the chemokine RANTES (Re-
leased upon Activation, Normal T-cell Expressed and Secreted,
or CCL5). This molecule belongs to a relatively limited set of
chemokines and adhesion molecules that are described to be
influencing atherogenesis through the recruitment of new cells to
the plaque [26,27]. In a recent publication, our group showed that
IFNb-induced expression of CCL5 augments the static adhesion of
macrophages to endothelial cells in vitro as well as the adhesion of
leukocytes to the vessel wall at atherosclerosis-prone sites in vivo,
thereby promoting the attraction of new cells to the plaques [28].
Macrophages from LysMCre-IkBa
fl/fl mice indeed adhered more
efficiently to an endothelial cell layer in vitro, while in the
atherosclerosis model, more monocytes were found adhering to
the endothelial layer covering the plaques in the IkBa
del mice
compared to the IkBa
WT mice.
To confirm the hypothesis that the lesions in the IkBa
del mice
were larger because of an increased attraction of leukocytes, we
applied a staining detecting a marker specific for immature
myeloid cells, ER-MP58. The target is an antigen with a yet
unknown function, which is present on the bone marrow-derived,
myeloid-committed progenitor cells. It continues to be expressed
on neutrophils and monocytes but disappears progressively upon
maturation of the M-CSF-responsive cells to macrophages [21,29].
Thus, both Ly-6C-high and Ly-6C-low subsets of circulating
monocytes are positive for ER-MP58 while tissue macrophages
have lost the marker [29,30]. Previously, detection of this marker
has been used to distinguish infiltrating immature myeloid cells
from the resident macrophages already present within the site of
inflammation, both in thioglycollate elicited macrophage recruit-
ment to the peritoneum [21,22] and in the restoration of the
Kupffer cell population in the liver, following injection with
liposome-entrapped dichloromethylene diphosphonate [23]. In
this paper, we show that ER-MP58 is also a valid marker for newly
recruited myeloid cells to the atherosclerotic plaque, with a
positivity that is limited to small, recently infiltrated cells in the
vicinity of the luminal plaque surface and inflammatory regions.
Contrary to the upregulation of CCL5 expression in the
LysMCre-IkBa
fl/fl macrophages, many typical NF-kB-dependent
genes were not influenced by the deletion of IkBa. This suggests
that in these cells, NF-kB is not continuously activated, but
inhibited by other feedback mechanisms which, like IkBa, prevent
NF-kB translocation to the nucleus or terminate NF-kB activation
by exporting it back to the cytoplasm. Indeed, studying the nuclear
translocation of several NF-kB subunits, we found that the
LysMCre-IkBa
fl/fl macrophages had the same degree of translo-
cation as wildtype cells (data not shown) and no increase in p65
phosphorylation was observed in the IkBa
del macrophages (Figure
S1B–C). In addition, only mild to no upregulation of other IkB
family members was detected by gene expression analysis, indi-
cating alternative mechanisms of regulation of NF-kB dependent
transcription. Recent studies indeed show that, besides IkB
inhibitors, also nuclear ubiquitin ligases can terminate chronic
NF-kB activation by its nuclear degradation, a mechanism that
might compensate the deletion of IkBa [31].
Figure 4. Deletion of IkBa in bone marrow-derived macrophages has limited effect on the expression of NF-kB-dependent
and/or –regulating genes but enhances in vitro static macrophage adhesion. (A) Gene expression in triplicates of LysMCre-IkBa
fl/fl
macrophages was compared to IkBa
fl/fl macrophages by Q-PCR. (B) Adhesion of fluorescently labeled macrophages to an endothelial monolayer (bars
represent triplicate wells 6 SEM; * p,0.05). Data shown are representative for at least 3 experiments.
doi:10.1371/journal.pone.0022327.g004
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resulted in an upregulation of the chemokine CCL5 and enhanced
static in vitro adhesion of macrophages to an endothelial cell layer.
Moreover, this correlated in vivo with increased leukocyte adhesion
to the activated endothelial lining of the blood vessel, enhanced
recruitment of ER-MP58
+ immature myeloid cells to the athero-
sclerotic plaqueand increasedatherosclerotic lesion formation inthe
aortic root and arch. Hereby we show that the role of myeloid IkBa
in the regulation of inflammation is complex but that it is involved in
the recruitment of macrophages to the atherosclerotic plaque.
Materials and Methods
Mice
C57BL/6 mice and ldlr
2/2 mice on a C57BL/6 background
were obtained from Jackson Laboratory (Bar Harbor, ME). IkBa
fl/fl
mice on a C57BL/6 background were described before [32]. All
animal experiments were approved by the DierExperimenten
Commissie (DEC) of the Maastricht University (permit numbers
2005-090 and 2009-168).
Bone marrow transplantation
One week before transplantation, female ldlr
2/2 mice were
housed in filter top cages and provided with acidified water
containing neomycin (100 mg/l; Gibco, Breda, The Netherlands)
and polymyxin B sulphate (6610
4 U/l; Gibco). The animals
received 10 Gy total body irradiation and on the following day,
bone marrow was isolated from 6 LysMCre-IkBa
fl/fl mice
(IkBa
del) and 6 IkBa
fl/fl littermates (IkBa
wt) and 10
7 cells/mouse
were injected intravenously to rescue the hematopoietic system of
the irradiated mice. Four weeks after the transplantation, mice
were fed a high fat diet (0.15% cholesterol, 16% fat, Arie Blok,
The Netherlands) for 12 weeks.
Mouse blood parameters
At several time points during the in vivo atherosclerosis
experiment, blood was drawn from the mice. Plasma lipid levels
were monitored enzymatically (Sigma Aldrich, Zwijndrecht, the
Netherlands) and plasma cytokine levels were measured by flow
cytometry using a Cytometric Bead Array kit (BD-Pharmingen,
San Diego, CA). Leukocytes were counted using a Coulter counter
and blood cell distribution was quantified by flow cytometry after
antibody staining with either Mac1-PE and Gr1-FITC for
macrophages and granulocytes or 6B2-PE and KT3-FITC for
B- and T-cells (BD-Pharmingen, Erembodegem, Belgium).
Atherosclerosis analysis
Upon sacrifice, the hearts from the bone marrow transplanted
mice were taken out and cut perpendicular to the heart axis just
below the atrial tips. Tissue was frozen in tissue-tec (Shandon,
Veldhoven, The Netherlands) and cut into sections of 7 mma s
described before [15]. Serial cross-sections from every 42 mm were
stained with toluidine blue. All lesion areas were quantified using
Adobe Photoshop software. The lesions were also typed according
to severity as early, moderate and advanced, as described before
[15].
Figure 5. Increased leukocyte adhesion and newly recruited myeloid cells in IkBa
del mice. (A) In IkBa
del mice, more leukocytes adhere to
the endothelial cell layer delineating the lesion (*** p,0.0001; n=17/17). Representative pictures from (B) IkBa
WT and (C) IkBa
del lesions, original
magnification6200. (D) Lesions from IkBa
del mice contain more ER-MP58 positive cells, suggesting an increased attraction myeloid cells (** p,0.001;
n=19/17). Representative pictures from (E) IkBa
WT and (F) IkBa
del lesions, original magnification 6200.
doi:10.1371/journal.pone.0022327.g005
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Lesions from the aortic root were fixed in acetone and
incubated with antibodies against neutrophils (1A8, BD-Pharmin-
gen), T cells (KT3, directed against CD3, a gift from G. Kraal),
proliferating cells (Ki-67, Dako, Glostrup, Denmark) and newly
recruited macrophages (ER-MP58, P. Leenen), followed by
detection with a biotin labeled rabbit anti-rat antibody and
staining with the ABC kit (Vector Labs, Burlingame, CA).
Apoptotic cells in the plaques were stained by the TUNEL
staining (Roche Diagnostics, Mannheim, Germany) according to
the manufacturer’s protocol. Collagen areas were analyzed on
Sirius red stained sections. Adhering leukocytes were quantified on
toluidine blue-stained sections.
In vitro murine bone marrow macrophage culture
Bone marrow cells were isolated from femurs and tibiae of
either wild-type (IkBa
fl/fl) or deleted (LysMCre-IkBa
fl/fl) mice.
Cells were cultured in RPMI-1640 (GIBCO Invitrogen, Breda,
The Netherlands) with 10% heat-inactivated fetal calf serum
(Bodinco B.V., Alkmaar, The Netherlands), penicillin (100 U/ml),
streptomycin (100 ug/ml), and L-glutamine 2 mM (all GIBCO
Invitrogen, Breda, The Netherlands) supplemented with 15%
L929-conditioned medium (LCM) for 8–9 days to generate bone
marrow-derived macrophages (BMM), as described previously
[15].
Western blotting
Protein was isolated from BMM with an SDS lysis buffer,
supplemented with complete protease inhibitor cocktail (Roche
Diagnostics) and PhosSTOP phosphatase inhibitor cocktail
(Roche Diagnostics). After Western blotting, blots were incubated
with P-p65 antibody (1:500, Cell Signaling, Danvers, MA) in PBS
with 0.05% Tween and 5% BSA (Sigma Aldrich).
Gene expression
RNA was isolated from BMM with the High Pure RNA
Isolation Kit (Roche, Basel, Switzerland) or from snap-frozen
aortic arches with the RNeasy Mini Kit (Qiagen, Venlo, The
Netherlands). 500 ng total RNA was reverse transcribed using the
iScript cDNA Synthesis Kit (BioRad, Veenendaal, The Nether-
lands). Quantitative PCR (Q-PCR) was performed using 10 ng
cDNA, 300 nM of each primer, and SensiMix (Quantace-Bioline,
London, UK) in a total volume of 20 ml. All gene expression levels
were corrected for cyclophilin A as housekeeping gene. Primer
sequences are available upon request.
In vitro adhesion assay
A confluent monolayer of bEND5 endothelial cells was grown
in fluorescence 96-well microplates (Greiner Bio-one, Frickenhau-
sen, Germany). Triplicate wells were incubated for 30 min with
10
5 BMM that had been fluorescently labeled with a PKH67 dye
according to the manufacturer’s instructions (Sigma Aldrich,
Zwijndrecht, The Netherlands). Subsequently, the wells were washed
three times with the aforementioned macrophage medium, and
adherent cells were measured by fluorometry in a Synergy HT
microtiter plate reader (BioTek, Bad Friedrichshall, Germany) at an
excitation of 485 nm and an emission of 520 nm.
Statistical analysis
The statistical analyses were performed using Graphpad Prism
(Graphpad Software). Differences between 2 groups were eva-
luated using a t-test, unless stated otherwise. Values are repre-
sented as mean 6 SEM. A P value of less than .05 was considered
to be statistically significant. All mouse data passed a normality
test.
Supporting Information
Figure S1 Deficiency of IkBa does not lead te increased
NF-kB activity and subsequent gene expression. (A)
Western blotting for IkBa on lysates of bone marrow derived
IkBa
WT or IkBa
del macrophages confirmed a reduction in IkBa
production, both before and after LPS activation. (B–C) A western
blot for phosphorylated NF-kB subunit p65 showed that NF-kBi s
not continuously activated in IkBa
del macrophages, (D) resulting
in a lack of differential expression patterns for NF-kB dependent
genes.
(TIF)
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